Advertisement Pfizer takes over Alacer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pfizer takes over Alacer

Pfizer has acquired Alacer, a provider of Vitamin C supplement products, based in Foothill Ranch, California, US.

Alacer produces nearly 500m packets of Emergen-C annually, and its products are sold in health food stores, supermarkets, drug stores, mass merchandisers and club stores.

Emergen-C is an effervescent, powdered drink mix vitamin supplement that supports active and healthy lifestyles.

Each of the seven lines of Emergen-C is packed with nutrients, Vitamins C and B, electrolytes and antioxidants.

Financial terms of the transaction have not been disclosed.

Lazard acted as financial advisor and DLA Piper (US) acted as legal advisor to Pfizer, in connection with the acquisition.

Houlihan Lokey acted as financial advisor and Rutan & Tucker acted as legal advisor to the owners of Alacer.

Pfizer Consumer Healthcare president Paul Sturman said Emergen-C products add to and complement the company’s dietary supplement portfolio.